ASPYRERX Trademark

Trademark Overview


On Friday, March 31, 2023, a trademark application was filed for ASPYRERX with the United States Patent and Trademark Office. The USPTO has given the ASPYRERX trademark a serial number of 97867943. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, February 13, 2024. This trademark is owned by Better Therapeutics, Inc.. The ASPYRERX trademark is filed in the Computer & Software Products & Electrical & Scientific Products category with the following description:

Downloadable mobile medical applications (MMA) for the treatment and management of cardiometabolic diseases and conditions; Downloadable mobile medical applications (MMA) prescribed by physicians for the treatment of cardiometabolic diseases and conditions; Downloadable mobile medical applications (MMA) delivering Cognitive Behavioral Therapy (CBT) for the management and treatment of cardiometabolic diseases; Downloadable Software as a Medical Device (SaMD) for the treatment of patients with cardiometabolic diseases and conditions; Downloadable software applications, namely, downloadable software for a prescription digital therapeutic providing cognitive behavioral therapy for the treatment of cardiometabolic diseases and conditions; Downloadable software for collecting self-reported biometric data and information from patients for the treatment of cardiometabolic diseases and conditions
aspyrerx

General Information


Serial Number97867943
Word MarkASPYRERX
Filing DateFriday, March 31, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, February 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 13, 2024

Trademark Statements


Goods and ServicesDownloadable mobile medical applications (MMA) for the treatment and management of cardiometabolic diseases and conditions; Downloadable mobile medical applications (MMA) prescribed by physicians for the treatment of cardiometabolic diseases and conditions; Downloadable mobile medical applications (MMA) delivering Cognitive Behavioral Therapy (CBT) for the management and treatment of cardiometabolic diseases; Downloadable Software as a Medical Device (SaMD) for the treatment of patients with cardiometabolic diseases and conditions; Downloadable software applications, namely, downloadable software for a prescription digital therapeutic providing cognitive behavioral therapy for the treatment of cardiometabolic diseases and conditions; Downloadable software for collecting self-reported biometric data and information from patients for the treatment of cardiometabolic diseases and conditions
Pseudo MarkASPIRE RX

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 038, 026, 023, 036
Class Status Code6 - Active
Class Status DateTuesday, April 25, 2023
Primary Code009
First Use Anywhere DateMonday, October 16, 2023
First Use In Commerce DateMonday, October 16, 2023

Trademark Owner History


Party NameBetter Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94104

Party NameBetter Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94104

Trademark Events


Event DateEvent Description
Tuesday, February 13, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 13, 2024PUBLISHED FOR OPPOSITION
Wednesday, January 24, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 5, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 5, 2024NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Thursday, January 4, 2024EXAMINER'S AMENDMENT ENTERED
Thursday, January 4, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 4, 2024EXAMINERS AMENDMENT E-MAILED
Thursday, January 4, 2024EXAMINERS AMENDMENT -WRITTEN
Thursday, January 4, 2024USE AMENDMENT ACCEPTED
Wednesday, December 27, 2023ASSIGNED TO EXAMINER
Sunday, November 12, 2023TEAS AMENDMENT OF USE RECEIVED
Monday, November 13, 2023AMENDMENT TO USE PROCESSING COMPLETE
Monday, November 13, 2023USE AMENDMENT FILED
Tuesday, April 25, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 4, 2023NEW APPLICATION ENTERED